NCT05232110Approved For Marketing不适用
Compassionate Use of Pozelimab
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
研究概览
简要总结
Provide compassionate use of pozelimab
详细描述
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
研究设计
- 研究类型
- Expanded Access
入排标准
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
Available
不适用
Compassionate Use or Expanded Access of DupilumabNCT04776694Regeneron Pharmaceuticals
No Longer Available
不适用
Compassionate Use of VidutolimodNCT06063746Regeneron Pharmaceuticals
No Longer Available
不适用
CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)Crohn's DiseaseNCT03559660UCB Biopharma SRL
Unknown
不适用
Compassionate Use of EvinacumabPediatric Homozygous Familial Hypercholesterolemia (HoFH)Severe Hypertriglyceridemia (HTG)Dysbetalipoproteinemia (DBL)NCT06500598Regeneron Pharmaceuticals
招募中
3 期
A study to examine the efficacy and safety of pozelimab and cemdisiran combination therapy in patients with symptomatic Generalized Myasthenia GravisCTRI/2023/02/049788Regeneron Pharmaceuticals, Inc.